A hand-held device that aims to reduce the disease burden for AMD patients
Ruth Steer |
AMD may well be treatable with anti-VEGF injections, but it comes at a cost to the patient: regular visits to the ophthalmologist’s office for disease monitoring with OCT. For elderly and visually impaired patients who require travel assistance, these frequent appointments can represent a further burden on their relatives – or their finances. A team from Universitätsklinikum Schleswig-Holstein, Kiel, and Medical Laser Center, Lübeck, Germany, have a potential solution in the form of a hand-held OCT device for home-monitoring of patients with retinal disease.
Given today’s advanced – and costly – OCT systems, what does a home-care setup look like, and how can it be achieved? “For a device to be used by the patients themselves, it needs to be small and low-cost,” explains Claus von der Burchard, Research Fellow at Universitätsklinikum Schleswig-Holstein. “To get there, we’ve had to make some compromises on image quality.” The result is off-axis full-field time-domain OCT (1). Von der Burchard explains: “We focused on reducing the scan area to 3 x 3 mm and using a full-field system which illuminates the whole field.” According to von der Burchard, the 3 x 3 images provide good sensitivity and specificity for monitoring subretinal and intraretinal fluid volume, and the full-field approach increases visual quality. “The design is also very simple, needing only a standard light source – rather than swept-source – and a regular, low-cost USB camera.”
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine